Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04863443 · ClinicalTrials.gov registry record
Nonlinear Elasticity Mapping of Breast Masses
A clinical trial of Breast Cancer, sponsored by Mayo Clinic.
- Completed
- Registry status
- 172
- Enrollment target
- 2
- Study locations
NCT04863443: Completed study of Breast Cancer, sponsored by Mayo Clinic.
NCT04863443 is a study of Breast Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 172 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04863443, a study of Breast Cancer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
- 2
- Study locations
Study Summary
This proposed technique, called "Nonlinear Elasticity Mapping (NEM)", is an innovative approach to estimate (i.e., linear and nonlinear) elasticity to provide complementary and relevant information for identification and characterization of breast masses. The proposed technique includes imaging the (nonlinear) elasticity parameter in a quantitative manner and measuring two new and relevant parameters. These parameters, together with linear elasticity, are used to differentiate breast masses. The first parameter is the nonlinearity of the elasticity.
Conditions Studied
Interventions
- DEVICE Ultrasound
Study Locations (2)
Minnesota
- Mayo Clinic Cancer Center - Rochester
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2014-07-24 |
| Est. Completion | 2025-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04863443
The ClinicalTrials.gov registry entry for NCT04863443 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT04863443 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04863443 about?
NCT04863443 is a clinical study titled "Nonlinear Elasticity Mapping of Breast Masses". This proposed technique, called "Nonlinear Elasticity Mapping (NEM)", is an innovative approach to estimate (i.e., linear and nonlinear) elasticity to provide complementary and relevant information for identification and characterization of breast masses. The proposed technique includes imaging the...
What is the current status of trial NCT04863443?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2014-07-24. Estimated completion is 2025-08-30.
What conditions does trial NCT04863443 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT04863443?
The interventions under investigation include: Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT04863443?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04863443 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.